Core Viewpoint - Hainan University has awarded contracts for the research instrument equipment update and replacement project for the Marine Science and Technology Innovation Platform (Phase II), with a total bid amount of 49.77 million yuan [1]. Procurement Results - The procurement results include multiple packages with various suppliers winning contracts: - Package 1: Guangdong Shengjie Instrument Co., Ltd. won with a bid of 3,191,000 yuan and a score of 99.06 [2]. - Package 2: Guangzhou Zhonglai Technology Co., Ltd. won with a bid of 6,207,900 yuan and a score of 99.57 [2]. - Package 4: Guangdong Shengjie Instrument Co., Ltd. won again with a bid of 3,880,500 yuan and a perfect score of 100 [3]. - Package 5: Guangdong Hanshuowei Instrument Equipment Co., Ltd. won with a bid of 4,996,800 yuan and a perfect score of 100 [4]. - Package 6: Guangdong Zhongke Import and Export Co., Ltd. won with a bid of 31,498,000 yuan and a perfect score of 100 [5]. Major Bid Information - The major bids include various scientific instruments: - Package 1 includes teaching instruments for the Marine Science and Engineering College, with a total bid of 3,191,000 yuan [7]. - Package 2 includes teaching instruments for the Marine Science and Engineering College, with a total bid of 6,207,900 yuan [7]. - Package 4 includes teaching instruments for the Chemical Engineering College, with a total bid of 3,880,500 yuan [7]. - Package 5 includes teaching instruments for the Chemical Engineering College, with a total bid of 4,996,800 yuan [7]. - Package 6 includes advanced mass spectrometry equipment from brands like Bruker and Thermo Scientific, with a total bid of 31,498,000 yuan [7]. Supplier Information - The suppliers involved in the project include: - Guangdong Shengjie Instrument Co., Ltd. [2][3] - Guangzhou Zhonglai Technology Co., Ltd. [2] - Guangdong Hanshuowei Instrument Equipment Co., Ltd. [4] - Guangdong Zhongke Import and Export Co., Ltd. [5] Contact Information - The procurement unit is Hainan University, located at 58 Renmin Avenue, Haikou, Hainan Province [8]. - The procurement agency is Zhongke Gaosheng Consulting Group Co., Ltd., located at 88 Binhai Road, Meilan District, Haikou, Hainan Province [9].

Core Viewpoint - The article highlights the launch of the first Fourier panoramic multimodal digital microscope by Xiguang Instrument, which boasts 100% independent intellectual property rights and offers advantages such as high resolution, large field of view, super depth of field, and rapid imaging, enabling multimodal imaging from micro to mesoscopic levels [1][2]. Group 1: Technology and Innovation - The new generation of computational optical imaging technology, Fourier Layered Microscopy (FPM), significantly reduces hardware complexity and costs while achieving high-performance imaging through innovative LED array lighting and advanced algorithms [3][5]. - The Fourier panoramic multimodal digital microscope incorporates the principle of "animal compound eyes" into its optical design, featuring a programmable LED light source array that captures light information from multiple angles, achieving a maximum resolution close to 200nm, with customizable options reaching 150nm [6][7]. - The imaging system supports various imaging modes, including bright field imaging, quantitative phase imaging, and polarization imaging, and can be integrated with laser confocal and Raman spectroscopy for comprehensive applications in life sciences and clinical diagnostics [7][10]. Group 2: Applications and Market Potential - The FPM technology has shown significant advancements in applications such as cell biology, tissue pathology, and cancer early screening, providing high-resolution imaging that enhances diagnostic accuracy and efficiency [9][10]. - The technology's high-throughput imaging capability allows for rapid imaging and analysis of large cell populations, making it suitable for large-scale drug screening [9][10]. - Xiguang Instrument aims to expand its product framework, offering a range of instruments from portable detection devices to high-end drug screening instruments, and plans to introduce more innovative products for various fields, including semiconductors and materials science [10][13]. Group 3: Company Background - Xiguang Instrument is a leading provider of computational optical imaging technology solutions, collaborating with institutions like the Chinese Academy of Sciences to develop high-throughput and high-content digital microscopes for various applications in life sciences, medical diagnostics, and industrial testing [13].

Core Viewpoint - The article highlights the recent government procurement intentions for various scientific instruments, totaling a budget of 181 million yuan, with procurement expected to occur between March and August 2025 [1]. Group 1: Procurement Overview - A total of 31 items related to scientific instruments have been identified for procurement, with a total budget of 181 million yuan [1]. - The procurement includes advanced equipment such as low-temperature scanning nano-magnetic imaging instruments, vehicle-mounted optical telescope systems, and X-ray diffraction instruments [1]. Group 2: Specific Equipment and Budget - Low-temperature scanning nano-magnetic imaging instrument with a budget of 9.98 million yuan, requiring specifications such as a spatial resolution of 10 nm and a sensitivity of 5 μT/Hz1/2 [3]. - Ventilation hoods for various applications, with a total budget of 2.25 million yuan for 20 units [3]. - Vehicle-mounted optical telescope system with a budget of 22 million yuan, requiring specific optical performance metrics [3]. - Strong magnetic low-temperature measurement system with a budget of 6.2 million yuan, designed for low-dimensional quantum device research [3]. - X-ray diffraction instrument with a budget of 3 million yuan, aimed at precise measurement of crystal lattice constants [3]. Group 3: Additional Equipment and Specifications - Various other instruments are included, such as a semiconductor device thermal stress lifetime analysis system, atomic layer deposition systems, and electron beam lithography systems, with budgets ranging from 1.55 million to 25.33 million yuan [4][5]. - The procurement also includes advanced laser systems, optical frequency comb systems, and chemical mechanical polishing machines, with specific technical requirements and warranty periods [4][5].

Core Viewpoint - The National Market Supervision Administration and eight other departments have jointly deployed the 2025 annual supervision and random inspection of testing and inspection institutions, planning to inspect 100 institutions across various key sectors [1][3]. Group 1: Inspection Plan - The 2025 national-level inspection plan includes checking 100 institutions, comprising 80 institutions recognized by the National Market Supervision Administration and 20 recognized at the provincial level [3]. - The inspection will focus on key regulatory areas, including: - 5 institutions in natural resource testing - 10 institutions in ecological environment monitoring or greenhouse gas emission testing - 5 institutions in vehicle inspection - 5 institutions in water quality monitoring - 5 institutions in import and export commodity inspection - 5 institutions in medical device protective equipment testing - 10 institutions in food inspection - 5 institutions each in fire products, building insulation materials, helmets and safety hats, hazardous chemicals, finished oil, and civil air defense equipment - 25 institutions in other fields [3][4]. Group 2: Responsibilities and Self-Inspection - Each testing and inspection institution is required to fulfill its primary responsibility, conduct self-risk assessments, and implement problem rectifications to reduce operational risks [4]. - Self-inspection focuses on compliance with national laws and regulations, adherence to principles of objectivity and fairness, adequacy of personnel and facilities, standardization of project subcontracting, and accuracy of testing data and results [4]. Group 3: Regulatory Approach - The notification emphasizes strict adherence to the "double random, one public" requirement, ensuring scientific, standardized, and transparent inspection processes [5]. - There will be a focus on cross-departmental collaborative regulation to reduce the burden on institutions, alongside the implementation of credit risk classification management for differentiated supervision [5].

Core Viewpoint - The article highlights a range of high-paying job opportunities in the scientific instrument sector, emphasizing the demand for skilled sales professionals in various companies across China [2][3][5][9][12]. Group 1: Job Opportunities - Agilent Technologies (China) Co., Ltd. is hiring for a sales position in Chongqing with a salary range of 10k-20k and requires a background in chemistry, pharmacy, or related fields [2]. - Hais Instrument Technology (Shanghai) Co., Ltd. is looking for a sales engineer in Chongqing with a salary range of 7k-10k [3]. - Bosted Technology Co., Ltd. is offering a sales engineer position in Beijing with a salary range of 6k-40k, requiring at least one year of sales or technical experience [5]. - Hangzhou Puyue Technology Development Co., Ltd. is seeking a sales engineer in Beijing with a salary range of 15k-25k, requiring over eight years of experience in the instrument industry [7][8]. - Ailimonte Trading (Shanghai) Co., Ltd. is hiring a sales engineer in Guangzhou with a salary range of 10k-11k [9]. Group 2: Job Requirements - Positions generally require a bachelor's degree or higher in relevant fields such as chemistry, biology, or environmental science [4][10][14]. - Many roles demand specific experience in sales or technical support within the scientific instrument sector, with some requiring over three years of relevant experience [8][11][21]. - Certain positions prefer candidates with experience in specific industries, such as pharmaceuticals, environmental testing, or materials analysis [10][12][20].

Core Viewpoint - The article discusses the current procurement trends and market dynamics of ICP-MS (Inductively Coupled Plasma Mass Spectrometry) instruments, highlighting the increasing demand for both imported and domestic brands in the customs sector of China [3][4][6]. Group 1: Market Overview - The ICP-MS instruments are experiencing a new wave of procurement, particularly in the customs sector, driven by the need for enhanced detection capabilities for import and export goods [3][4]. - From November 2024 to the present, there have been 44 procurement announcements for ICP-MS, totaling 45 units with a combined bid amount exceeding 56.35 million yuan [3][4]. Group 2: Regional Distribution - The East China region shows the highest demand for ICP-MS, with 25 units procured, accounting for 56% of total purchases. Key provinces include Shandong, Jiangsu, and Fujian [4]. - The South China region follows with 7 units (16%), while the Northwest region accounts for 5 units (11%) [4]. Group 3: Brand Performance - The procurement data includes 6 brands of ICP-MS, with both imported and domestic brands having equal representation. The leading imported brands are Agilent, PerkinElmer, and Thermo Fisher, while the domestic brands include Puyutech, Labtech, and Hengsheng [6][10]. - Agilent leads the market with a 48% share, followed by PerkinElmer at 26%, and Thermo Fisher at 12%. Domestic brands are also gaining traction, indicating a trend towards domestic substitution [10][13]. Group 4: Popular Models - The most popular models during the procurement period include Agilent's 7850, PerkinElmer's NexION 1100G, and Thermo Fisher's iCAP RQ Plus among imported brands. For domestic brands, Puyutech's SUPEC 7000, Labtech's LabMS 3000, and Hengsheng's iQuad 2300 are notable [14][15].

Core Viewpoint - Quanterix has completed the acquisition of Akoya Biosciences through a stock and cash transaction, aiming for technological complementarity and market expansion [1]. Group 1: Acquisition Details - On July 8, 2025, Quanterix announced the completion of the acquisition of Akoya Biosciences, issuing 78 million shares of common stock and paying $20 million in cash [2]. - The acquisition was structured as 1 share of Akoya stock exchanged for 0.1461 shares of Quanterix stock plus $0.38 in cash [2]. - The acquisition process began in early 2025, with initial terms proposing 1 share of Akoya stock for 0.318 shares of Quanterix stock [3]. Group 2: Strategic Objectives - The acquisition aims to combine Akoya's spatial biology with Quanterix's ultra-sensitive protein detection technology, creating technological synergies [3]. - The deal is expected to expand application areas from neurology to oncology, leveraging Akoya's partnerships to drive product entry into clinical markets [3]. - The transaction is projected to generate approximately $40 million in annual cost synergies, with $20 million expected to be realized in the first year post-transaction [3]. Group 3: Company Background - Quanterix Corporation (NASDAQ: QTRX) is a life sciences company based in Billerica, Massachusetts, founded in 2007, focusing on ultra-sensitive biomarker detection [4]. - The company's core innovation is the Simoa® (Single Molecule Array) technology, which allows for the detection of proteins and nucleic acids in blood, plasma, or serum at femtogram per milliliter sensitivity [4]. - The merger and technology integration will expand Quanterix's business from single protein detection to spatial biology, potentially enhancing its role in multi-omics research and personalized medicine [4].

Core Viewpoint - Guangdong Meisi Scientific Instrument Innovation Research Institute has successfully developed and delivered a customized gas chromatography-high-resolution time-of-flight mass spectrometry (GC-HRTOFMS) system, which features high resolution and switchable ion sources, suitable for complex sample analysis [1][2]. Group 1 - The GC-HRTOFMS system was commissioned by a university and has passed all technical tests upon delivery, now officially in use [2]. - The instrument integrates separation and high-precision detection, with a mass resolution exceeding 5000 [2]. - The switchable ion source design (photoionization source and EI source) significantly enhances the coverage and qualitative capabilities of compounds, allowing for accurate analysis of complex samples [2]. Group 2 - The system is applicable in various research fields, including chemistry and environmental studies, due to its ability to efficiently separate components in complex samples and accurately determine molecular weights and structural analysis [2].

Core Viewpoint - Zhejiang Helhu Technology Co., Ltd. has successfully completed a multi-million Pre-A round financing, focusing on high-end microscopy technology to advance research in brain science and immunotherapy, thereby accelerating the development of domestic high-end instruments [1][2]. Company Overview - Founded in November 2020, Helhu Technology is led by Tsinghua University academicians and relies on the Tsinghua University Institute of Brain and Cognitive Science, gathering experts from information technology, optics, and life sciences [2]. - The company is a key project in the biomedical field in Hangzhou Future Science City and is responsible for the transformation of major achievements from the National Natural Science Foundation [2]. Technological Advancements - Helhu Technology has developed the world's first scanning light field microscopy architecture, overcoming three major challenges in live mesoscopic microscopy, achieving ultra-large field of view, high-speed, high-resolution, and long-duration imaging [3]. - The company has mastered core technologies in microscopic imaging, organoid culture, and cognitive computing, providing comprehensive solutions for life science research, drug development, and precision medicine [2][3]. Product Offerings - The company currently offers three flagship products: - SLiM series for high-speed, high-resolution live 3D imaging, applied in significant research such as migration mechanism discovery [4]. - RUSH3D system for continuous observation at the centimeter scale, aiding research in brain science and tumor immunology [4]. - RUSH-mini head-mounted microscope designed for lightweight operation, enabling large field imaging of freely moving mice [4]. - These products serve over ten universities and research institutions, accelerating the domestic production of life science instruments [5].

Core Viewpoint - The company is making steady progress in its application for public stock issuance and listing on the Beijing Stock Exchange, with positive developments in governance, financial, and legal compliance aspects, adding new momentum to the high-end testing equipment industry [1][12]. Group 1: Listing Progress - On July 9, the company announced its application for public stock issuance and listing guidance on the Beijing Stock Exchange [2]. - The company signed a written guidance agreement with Northeast Securities on April 12, 2023 [4]. - The company submitted its guidance filing materials to the Jilin Securities Regulatory Bureau on April 13, 2023, with Northeast Securities as the guidance institution [5]. - The Jilin Securities Regulatory Bureau accepted the company's guidance filing materials on April 17, 2023, marking the start of the guidance period [6]. - As of the announcement date, the guidance work is proceeding normally, with Northeast Securities submitting a progress report to the Jilin Securities Regulatory Bureau [7][8]. Group 2: Financial Compliance - The company has disclosed its recent financial data, indicating that the net profit attributable to shareholders for 2023 and 2024 is projected to be approximately CNY 47.99 million and CNY 39.09 million, respectively [9]. - The weighted average return on net assets for the same periods is expected to be 12.01% and 8.87%, meeting the financial conditions required for listing on the Beijing Stock Exchange [9]. - The company is committed to complying with legal and regulatory requirements and will continue to update investors on the progress of its listing application [12].